Harry McCann

Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN Log In
Harry McCann
Non-Executive Chair / Telix Pharmaceuticals

Lists and Charts

Total Shareholder Return as at 31/10/24

RankCompany1 yr5 yr
105thTelix Pharmaceuticals137%66%
View Full List
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Roles

2017
Non-Executive Chair
Telix Pharmaceuticals
Year started and most recent title

Revenue

RankCompanyRevenue
th-Telix Pharmaceuticals$499.1m
View Full List
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options